sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> dna vaccines market

report

DNA Vaccines Market, by Therapeutic Indications (Vector Borne Disease and Cancer), End-users (Humans and Animals), Types of Vaccines (Genetic Vaccines and Recombinant Protein Vaccines) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC154 October 2016 100+ FREE 10% CUSTOMIZATION

The global DNA vaccines market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the DNA vaccines market.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The global market for DNA immunization is strongly being affected by the points of interest connected with the new era of vaccines that have less symptoms, ease of applications, and lower costs. These vaccines are preceded with the strong advancements in the biotechnology field.
  • As per the World Health Organization (WHO), ~18 million individuals die every year because of the inaccessibility of a compelling treatment for their fatal illness, which show the global significance of some of the fatal diseases.
  • The aforementioned factor also indicates the strong requirement for the suitable DNA immunizations makers, which is one of the major driving factors for the DNA vaccines market.
  • Additionally, the rapid advancements in the field of sub-atomic science, immunology, and DNA combinations would encourage the growth and development opportunities in the DNA vaccines market during the forecast period.
  • Some of the factors such as inappropriate drug therapies and the increased microbial resistance will further boost the DNA vaccine market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s DNA vaccines market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the DNA vaccines market by the following segments:

  • DNA Vaccines Market, by Therapeutic Indications
    • Vector Borne Disease
    •  Cancer
  • DNA Vaccines Market, by End-users
    • Humans
    • Animals
  • DNA Vaccines Market, by Types Of Vaccines
    • Genetic Vaccines
    • Recombinant Protein Vaccines

KEY MARKET PLAYERS

Key players in the DNA vaccines market include:

  • GlaxoSmithKline PLC
  • Serum Institute of India
  • Bharat Biotech
  • Indian Immunologicals Limited
  • Merck & Co.
  • Green Cross Corporation
  • Novartis AG
  • Sanofi
  • Protein Sciences Corporation
  • Zoetis, Inc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

DNA Vaccines Market

TRENDING RELATED REPORT

Stem Cell Therapy Market, by Treatments (Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy), Applications (Central Nervous System Diseases, Eye Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Gastrointestinal Disorders and Immune System Disorders), End-users (Hospitals and Ambulatory Surgical Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Pricing Analysis
    3. Regulatory Analysis
    4. Reimbursement Landscape
  5. DNA VACCINES MARKET, BY THERAPEUTIC INDICATIONS
    1. Segment Share
    2. By Therapeutic Indications
      1. Vector Borne Disease
      2.  Cancer
  6. DNA VACCINES MARKET, BY END USERS
    1. Segment Share
    2. By End-users
      1. Humans
      2. Animals
  7. DNA VACCINES MARKET, BY TYPES OF VACCINES
    1. Segment Share
    2. By Type of Vaccines
      1. Genetic Vaccines
      2. Recombinant Protein Vaccines
  8. DNA VACCINES MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By End-users
      3. By Therapeutic Indications
      4. By Type of vaccines
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K
        4. Rest of Europe
      2. By End-users
      3. By Therapeutic Indications
      4. By Type of vaccines
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By End-users
      3. By Therapeutic Indications
      4. By Type of vaccines
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By End-users
      3. By Therapeutic Indications
      4. By Type of vaccines
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovator Companies
  10. KEY MARKET PLAYERS
    1. GlaxoSmithKline PLC
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Serum Institute of India Pvt. Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Bharat Biotech
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Indian Immunologicals Limited
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Merck & Co.,Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Green Cross Corporation
      1.  Overview
      2. Key Strategies
      3. Recent Developments
    7. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Sanofi SA
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Protein Sciences Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Zoetis
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us